Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cytokines--soluble factors in immune responses.

× No keyword cloud information.

8 in total

1. EGCG induces G-CSF expression and neutrophilia in experimental sepsis.

Authors: Wei Li; Andrew H Wu; Shu Zhu; Jianhua Li; Rong Wu; John D'Angelo; Haichao Wang
Journal: Immunol Res Date: 2015-12 Impact factor: 2.829

Review 2. Mechanisms of immune-mediated demyelinating disease of the central nervous system.

Authors: D Baker; A N Davison
Journal: Neurochem Res Date: 1991-09 Impact factor: 3.996

3. Reversal of mucosal tolerance by subcutaneous administration of interleukin-12 at the site of attempted sensitization.

Authors: A M Claessen; B M von Blomberg; J De Groot; D A Wolvers; G Kraal; R J Scheper
Journal: Immunology Date: 1996-07 Impact factor: 7.397

4. Use of animal model of sepsis to evaluate novel herbal therapies.

Authors: Wei Li; Shu Zhu; Yusong Zhang; Jianhua Li; Andrew E Sama; Ping Wang; Haichao Wang
Journal: J Vis Exp Date: 2012-04-11 Impact factor: 1.355

5. Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers.

Authors: Shu Zhu; Mala Ashok; Jianhua Li; Wei Li; Huan Yang; Ping Wang; Kevin J Tracey; Andrew E Sama; Haichao Wang
Journal: Mol Med Date: 2009-05-01 Impact factor: 6.354

Review 6. High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors: Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal: Inflamm Allergy Drug Targets Date: 2010-03

Review 7. Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.

Authors: Haichao Wang; Mary F Ward; Andrew E Sama
Journal: Shock Date: 2009-10 Impact factor: 3.454

Review 8. Therapeutic potential of HMGB1-targeting agents in sepsis.

Authors: Haichao Wang; Shu Zhu; Rongrong Zhou; Wei Li; Andrew E Sama
Journal: Expert Rev Mol Med Date: 2008-11-04 Impact factor: 5.600

8 in total